A high concentration of CCL4 has been identified in secretions of patients with severe COVID-19, although its expression has also been found in dengue-infected dendrites, promoting vasodilatation and endothelial dysfunction in both diseases.22 This evidence concerns the gene CCL4 and COVID-19.